Cash Flow Statement
Growth Metrics

Mimedx (MDXG) Receivables - Other (2017 - 2021)

Mimedx recorded quarterly Receivables - Other of $400000.0 in Q2 2021, down 42.86% quarter-over-quarter from $700000.0 in Q1 2021.

Mimedx's Receivables - Other history runs 5 years deep, the most recent figure standing at $400000.0 for Q2 2021.

  • In Q2 2021, Receivables - Other changed N/A year-over-year to $400000.0; the TTM figure through Jun 2021 stood at $400000.0 (changed N/A YoY), while the FY2020 annual figure was $200000.0, down 84.14% from the prior year.
  • Receivables - Other came in at $400000.0 for Q2 2021 at Mimedx, down from $700000.0 in the prior quarter.
  • In the past five years, Receivables - Other ranged from a high of $5.9 million in Q4 2017 to a low of $200000.0 in Q4 2020.
  • A 5-year average of $2.0 million and a median of $980500.0 in 2019 frame the typical range for Receivables - Other.
  • Across the five-year window, Receivables - Other slumped 84.14% in 2020 and increased 16.67% in 2021, its largest moves.
  • Mimedx's Receivables - Other stood at $5.9 million in 2017, then dropped by 27.12% to $4.3 million in 2018, then sank by 70.67% to $1.3 million in 2019, then plunged by 84.14% to $200000.0 in 2020, then jumped by 100.0% to $400000.0 in 2021.
  • According to Business Quant data, Receivables - Other over the past three periods registered $400000.0, $700000.0, and $200000.0 for Q2 2021, Q1 2021, and Q4 2020 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Mimedx 530.69 Mn 370.92 Mn 41.62 Mn

Historic Data

Download Data 🔒
DateValue
Jun 30, 2021 400,000.00
Jun 30, 2021 400,000.00
Mar 31, 2021 700,000.00
Mar 31, 2021 700,000.00
Dec 31, 2020 200,000.00
Dec 31, 2020 200,000.00
Mar 31, 2020 600,000.00
Mar 31, 2020 600,000.00
Dec 31, 2019 1.26 Mn
Dec 31, 2019 1.26 Mn
Sep 30, 2019 2.41 Mn
Sep 30, 2019 2.41 Mn
Dec 31, 2018 4.30 Mn
Dec 31, 2018 4.30 Mn
Dec 31, 2017 5.90 Mn
Dec 31, 2017 5.90 Mn